DFCM
KYMR icon

Dark Forest Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Dark Forest Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.81M Sell
21,760
-17,447
-44% -$1.38M 0.16% 178
2025
Q4 		$3.05M Buy
39,207
+8,155
+26% +$551K 0.14% 227
2025
Q3 		$1.76M Buy
31,052
+5,102
+20% +$230K 0.07% 511
2025
Q2 		$1.13M Sell
25,950
-28,204
-52% -$971K 0.05% 697
2025
Q1 		$1.48M Buy
54,154
+43,905
+428% +$1.6M 0.07% 497
2024
Q4 		$412K Buy
10,249
+5,839
+132% +$264K 0.06% 525
2024
Q3 		$209K Buy
+4,410
New +$195K 0.03% 852
2023
Q4 		– Sell
-36,698
Closed -$510K – 809
2023
Q3 		$510K Buy
36,698
+17,280
+89% +$347K 0.04% 711
2023
Q2 		$446K Buy
19,418
+11,376
+141% +$326K 0.04% 674
2023
Q1 		$238K Buy
+8,042
New +$259K 0.06% 315
2022
Q4 		– Sell
-267
Closed -$6K – 1330
2022
Q3 		$6K Sell
267
-231
-46% -$6.09K ﹤0.01% 849
2022
Q2 		$10K Buy
498
+425
+582% +$9.93K ﹤0.01% 528
2022
Q1 		$3K Buy
73
+4
+6% +$169 ﹤0.01% 1147
2021
Q4 		$4K Sell
69
-779
-92% -$45.4K ﹤0.01% 1227
2021
Q3 		$50K Buy
848
+823
+3,292% +$47.7K 0.02% 564
2021
Q2 		$1K Buy
+25
New +$1.08K ﹤0.01% 784

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Dark Forest Capital Management's KYMR Position: Q1 2026 in Review

Dark Forest Capital Management reduced its Kymera Therapeutics (KYMR) stake by 44% in Q1 2026, selling an estimated $1.38M and leaving 21,760 shares worth $1.81M. The position accounts for 0.16% of the portfolio, ranked #178.

Dark Forest Capital Management first reported a position in KYMR in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.05M in Q4 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Dark Forest Capital Management held 21,760 shares of Kymera Therapeutics worth $1.81M as of Q1 2026.
  • Dark Forest Capital Management sold 17,447 Kymera Therapeutics shares in Q1 2026, an estimated $1.38M.
  • Kymera Therapeutics made up 0.16% of Dark Forest Capital Management's portfolio in Q1 2026, its #178 holding.
  • Dark Forest Capital Management first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Dark Forest Capital Management's Kymera Therapeutics position peaked at $3.05M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.